https://stock.noler.com/us/stock/china-gewang-biotechnology-inc https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/accounts-payable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/accounts-payable-interest-bearing-interest-rate https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/accounts-receivable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/accounts-receivable-net https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/accrued-liabilities-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/accumulated-depreciation https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/accumulated-oci-before-tax https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/additional-paid-in-capital https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/advertising-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/advertising-revenue https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/aoci https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/assets-net https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/assets-noncurrent https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/basic-shares https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/cash https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/cash-and-equivalents https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/cash-change https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/cash-flow-breakdown https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/common-stock-value https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/communications-and-information-technology https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/comprehensive-income https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/concentration-risk-percentage https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/cost-of-goods-sold https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/current-assets https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/current-liabilities https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/debt-interest-rate https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/deferred-costs https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/deferred-revenue https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/depreciation https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/due-to-related-parties-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/effect-of-exchange-rate-on-cash https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/eps-basic https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equipment-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-issuance-dollar-amount-per-share https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-method-investment-summarized-financial-information-cost-of-sales https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-method-investment-summarized-financial-information-current-assets https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-method-investment-summarized-financial-information-current-liabilities https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-method-investment-summarized-financial-information-equity https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-method-investment-summarized-financial-information-net-income-loss https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-method-investment-summarized-financial-information-noncurrent-assets https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-method-investment-summarized-financial-information-revenue https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/equity-method-investments https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/financing-cash-flow https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/foreign-currency-transaction-loss-before-tax https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/form-d-stocks https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/gain-or-loss-on-sale-of-previously-unissued-stock-by-equity-investee https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/general-and-administrative-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/gross-profit https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/income-loss-from https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/income-loss-from-attributable-to-noncontrolling-entity https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/income-tax https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/income-taxes-paid https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-accrued-taxes-payable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/interest-and-debt-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/interest-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/interest-income-other https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/inventory https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/investing-cash-flow https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/investment-income-interest https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/lease-and-rental-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/liabilities-noncurrent https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/license-costs https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/licenses-revenue https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/loans-payable-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/management-fees-revenue https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/marketing-and-advertising-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/minority-interest https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/net-cash-from https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/net-income https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/net-income-loss-attributable-to-redeemable-noncontrolling-interest https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/notes-payable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/notes-payable-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/oci-before-tax https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/oci-before-tax-2 https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/oci-before-tax-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/oci-net-of-tax https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/oci-net-of-tax-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/oci-other-net-of-tax https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/operating-cash-flow https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/operating-expenses https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/operating-income https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-assets https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-assets-miscellaneous-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-income https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-intangible-assets-net https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-loans-payable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-nonoperating-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-nonoperating-income https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-operating-income-expense-net https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/other-receivables-net-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/payments-for-proceeds-from-investments https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/prepaid-expense-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/prepaid-expense-current-and-noncurrent https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/pretax-income https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/proceeds-from-loans https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/proceeds-from-unsecured-notes-payable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/profit-loss https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/property-plant-and-equipment-other https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/property-plant-equipment https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/public-float https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/research-and-development https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/retail-revenue https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/retained-earnings https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/revenue https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/sales-revenue-goods-gross https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/sales-revenue-net https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/secured-demand-notes https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/share-based-goods-and-nonemployee-services-transaction-expense https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/share-based-goods-and-nonemployee-services-transaction-quantity-of-securities-issued https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/shareholders-equity https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/shares-authorized https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/shares-issued https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/shares-issued-value-issued-for-services https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/stock-based-compensation https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/stockholders-equity-before-treasury-stock https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/taxes-payable-current https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/taxes-payable-current-and-noncurrent https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/total-assets https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/total-liabilities https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/variable-interest-entity-activity-between-vie-and-entity-revenues https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/variable-interest-entity-consolidated-carrying-amount-assets https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/variable-interest-entity-nonconsolidated-carrying-amount-assets https://stock.noler.com/us/stock/china-gewang-biotechnology-inc/weighted-average-number-of-share-outstanding-basic-and-diluted